Clinical trial
Bortezomib-Dexamethasone-Doxorubicin-Study
NCT00401804 · Austrian Forum Against Cancer, Other · Completed
Key facts
| NCT number | NCT00401804 |
|---|---|
| Title | Bortezomib-Dexamethasone-Doxorubicin-Study |
| Official title | Bortezomib-Doxorubicin-Dexamethasone as Treatment for Patients With Multiple Myeloma Presenting With Acute Renal Failure |
| Lead sponsor | Austrian Forum Against Cancer, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Renal Insuficiency |
| Intervention type | Drug |
| Interventions | Dexamethasone, Bortezomib, Doxorubicin |
| Enrollment | 72 |
| Start date | Feb 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | Nov 22, 2006 |
| Last update posted | Jan 24, 2013 |
| Countries | Austria, Czechia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: